Understanding your starting dose Everyone begins semaglutide treatment at the same low dose
I wouldnt want to give a random peptide to patient A, and then give what I think is the same thing to patient B but I dont know if its the same thing, because its from a different company or its not standardized, Frank said
However, for a peptide like BPC-157 that works on regeneration over time, a steady, sustained release (as often seen with subcutaneous injections) may be more advantageous
Average responders (~60% of patients): Weight loss of 23 kg over 6 months, plateauing thereafter
[DOI] [PubMed] [Google Scholar] 73.Viswanatha GL, Shylaja H, Moolemath Y
que si el tratamiento con GLP-1 ya estaba establecido, es posible comenzar con la dosis de mantenimiento del nuevo medicamento, sin necesidad de utilizar las dosis de inicio